Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis

Cytokine

Volumn 46, Issue 2, 2009, Pages 187-193

  Kamei, Satoshi ^a   Taira, Naoto ^a   Ishihara, Masaki ^a   Sekizawa, Tsuyoshi ^b   Morita, Akihiko ^a   Miki, Kenji ^a   Shiota, Hiroshi ^a   Kanno, Akira ^a   Suzuki, Yutaka ^a   Mizutani, Tomohiko ^a   Itoyama, Yasuto ^c   Morishima, Tsuneo ^d   Hirayanagi, Kaname ^e  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e NIHON UNIVERSITY   (Japan)

Author keywords

Corticosteroid; Herpes simplex virus encephalitis; Interferon ; Interleukin 6; Outcome

Indexed keywords

ACICLOVIR; BIOLOGICAL MARKER; CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; ETHINYLESTRADIOL PLUS MEGESTROL ACETATE; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; DRUG MECHANISM; FEMALE; HERPES SIMPLEX ENCEPHALITIS; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ACYCLOVIR; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CYTOKINES; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-6; MALE; MIDDLE AGED; PROGNOSIS; SIMPLEXVIRUS; TREATMENT OUTCOME; YOUNG ADULT;

SIMPLEXVIRUS;

EID: 65049090344     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.01.004     Document Type: Article

References (21)

1. Whitley R.J., and Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis 20 (1995) 414-420
2. Whitley R.J., Alford C.A., Hirsh M.S., Schooley R.T., Luby J.P., Aoki F.Y., et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 314 (1986) 144-149
3. Sköldenberg B., Forsgren M., Alestig K., Bergström T., Burman L., Dahlqvist E., et al. Acyclovir versus vidarabine in herpes simplex encephalitis: randomised multicentre study in consecutive Swedish patients. Lancet 2 (1984) 707-711
4. Kamei S., Sekizawa T., Shiota H., Mizutani T., Itoyama Y., Takasu T., et al. Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatr 76 (2005) 1544-1549
5. Solomon T., Hart I.J., and Beeching N.J. Viral encephalitis: a clinician's guide. Pract Neurol 7 (2007) 288-305
6. Fitch M.T., and van de Beek D. Drug insight: steroids in CNS infectious diseases-new indications for an old therapy. Nat Clin Pract Neurol 4 (2008) 97-104
7. Asaoka K., Shoji H., Nishizaka S., Ayabe M., Abe T., Ohori N., et al. Non-herpetic acute limbic encephalitis: cerebrospinal fluid cytokines and magnetic resonance imaging findings. Intern Med 43 (2004) 42-48
8. Aurelius E., Andersson B., Forsgren M., Sköldenberg B., and Strannegård O. Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis. J Infect Dis 170 (1994) 678-681
9. Rösler A., Pohl M., Braune H.J., Oertel W.H., Gemsa D., and Sprenger H. Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis. J Neurol Sci 157 (1998) 82-89
10. Ichiyama T., Shoji H., Takahashi Y., Matsushige T., Kajimoto M., Inuzuka T., et al. Cerebrospinal fluid levels of cytokines in non-herpetic acute limbic encephalitis: comparison with herpes simplex encephalitis. Cytokine 44 (2008) 149-153
11. Whitley R.J., Cobbs C.G., Alford C.A., Soong S.J., Hirsch M.S., Connor J.D., et al. Diseases that mimic herpes simplex encephalitis: diagnosis, presentation and outcome. JAMA 262 (1989) 234-239
12. Sellner J., Dvorak F., Zhou Y., Haas J., Kehm R., Wildemann B., et al. Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis. Neurosci Lett 374 (2005) 197-202
13. Geiger K.D., Nash T.C., Sawyer S., Krahl T., Patstone G., Reed J.C., et al. Interferon-gamma protects against herpes simplex virus type 1-mediated neuronal death. Virology 238 (1997) 189-197
14. Shimeld C., Whiteland J.L., Williams N.A., Easty D.L., and Hill T.J. Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J Gen Virol 78 Pt. 12 (1997) 3317-3325
15. Dvorak F., Martinez-Torres F., Sellner J., Haas J., Schellinger P.D., Schwaninger M., et al. Experimental herpes simplex virus encephalitis: a long-term study of interleukin-6 expression in mouse brain tissue. Neurosci Lett 367 (2004) 289-292
16. Oshima M., Azuma H., Suzutani T., Ikeda H., and Okuno A. Direct and mononuclear cell mediated effects on interleukin 6 production by glioma cells in infection with herpes simplex virus type 1. J Med Virol 63 (2001) 252-258
17. Winter P.M., Dung N.M., Loan H.T., Kneen R., Wills B., Thu le T., et al. Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J Infect Dis 190 (2004) 1618-1626
18. Samuel C.E. Antiviral actions of interferon: interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183 (1991) 1-11
19. Finke D., Brinckmann U.G., ter Meulen V., and Liebert U.G. Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol 69 (1995) 5469-5474
20. Thompson K.A., Blessing W.W., and Wesselingh S.L. Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal herpes encephalitis. J Neurovirol 6 (2000) 25-32
21. Meyding-Lamade U.K., Oberlinner C., Rau P.R., Seyfer S., Heiland S., Sellner J., et al. Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol 9 (2003) 118-125